Good, bad, and neglectful: Astrocyte changes in neurodegenerative disease.


Journal

Free radical biology & medicine
ISSN: 1873-4596
Titre abrégé: Free Radic Biol Med
Pays: United States
ID NLM: 8709159

Informations de publication

Date de publication:
03 2022
Historique:
received: 17 01 2022
revised: 11 02 2022
accepted: 18 02 2022
pubmed: 25 2 2022
medline: 6 4 2022
entrez: 24 2 2022
Statut: ppublish

Résumé

Astrocytes play key roles in CNS development as well as well as neuro-supportive roles in the mature brain including ionic, bioenergetic and redox homeostasis. Astrocytes undergo rapid changes following acute CNS insults such as stroke or traumatic brain injury, but are also profoundly altered in chronic neurodegenerative conditions such as Alzheimer's disease. While disease-altered astrocytes are often referred to as reactive, this does not represent a single cellular state or group of states, but a shift in astrocyte properties that is determined by the type of insult as well as spatio-temporal factors. Such changes can accelerate disease progression due to astrocytes neglecting their normal homeostatic neuro-supportive roles, as well as by gaining active neuro-toxic properties. However, other aspects of astrocytic responses to chronic disease can include the induction of adaptive-protective pathways. This is particularly the case when considering antioxidant defences, which can be up-regulated in many cell types, including astrocytes, in response to stresses, sometimes in concert with the activation of detoxification and proteostasis pathways. Protective responses, whilst potentially serving to mitigate neuronal dysfunction, may ultimately fail due to being insufficiently strong, or be offset by other deleterious changes to astrocytes occurring in parallel. Nevertheless, a greater understanding of early adaptive-protective responses of astrocytes to neurodegenerative disease pathology may point to ways in which these responses may be harnessed for therapeutic effect.

Identifiants

pubmed: 35202786
pii: S0891-5849(22)00073-9
doi: 10.1016/j.freeradbiomed.2022.02.020
pmc: PMC8969603
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-99

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : PCL/20/05
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Nature. 1993 Mar 4;362(6415):59-62
pubmed: 8446170
Ann Neurol. 1996 Nov;40(5):759-66
pubmed: 8957017
Cold Spring Harb Perspect Biol. 2015 Feb 13;7(12):
pubmed: 25680832
J Neurosci. 2015 Feb 11;35(6):2817-29
pubmed: 25673868
J Neurosci. 2012 Nov 14;32(46):16129-40
pubmed: 23152597
J Exp Med. 2018 Jun 4;215(6):1649-1663
pubmed: 29724785
Free Radic Biol Med. 2015 Nov;88(Pt B):253-267
pubmed: 26281945
Glia. 1996 Mar;16(3):276-84
pubmed: 8833198
Neurobiol Aging. 2014 Dec;35(12):2746-2760
pubmed: 25002035
Toxicol Appl Pharmacol. 2012 Nov 1;264(3):431-8
pubmed: 22959925
J Immunol. 1996 Oct 15;157(8):3569-76
pubmed: 8871657
J Anat. 2002 Jun;200(6):629-38
pubmed: 12162730
Science. 2001 Nov 9;294(5545):1354-7
pubmed: 11701931
Neuron. 2014 Mar 5;81(5):1001-1008
pubmed: 24508385
Neuron. 2017 Mar 22;93(6):1420-1435.e5
pubmed: 28285822
Cells. 2021 Jan 28;10(2):
pubmed: 33525344
Glia. 2000 Oct;32(1):1-14
pubmed: 10975906
Cell Death Differ. 2012 May;19(5):779-87
pubmed: 22095276
Cell Stem Cell. 2008 Dec 4;3(6):649-57
pubmed: 19041781
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Nat Commun. 2017 May 02;8:15132
pubmed: 28462931
Redox Biol. 2021 Nov;47:102158
pubmed: 34626892
Neurobiol Aging. 2004 Jan;25(1):63-9
pubmed: 14675732
Cell Metab. 2021 Aug 3;33(8):1546-1564
pubmed: 34348099
Nature. 2019 Jun;570(7761):332-337
pubmed: 31042697
Int J Mol Sci. 2020 Mar 12;21(6):
pubmed: 32178355
Nat Metab. 2019 Feb;1(2):201-211
pubmed: 32694785
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):E1-2; author reply E3-4
pubmed: 21177433
Nature. 2021 Nov;599(7883):102-107
pubmed: 34616039
Nat Commun. 2022 Jan 10;13(1):135
pubmed: 35013236
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Nat Neurosci. 2019 Dec;22(12):2087-2097
pubmed: 31768052
Neurosci Biobehav Rev. 2016 Dec;71:484-505
pubmed: 27693230
J Neurosci. 2008 Dec 10;28(50):13574-81
pubmed: 19074031
Front Neurosci. 2014 May 09;8:103
pubmed: 24847203
Nat Neurosci. 2007 May;10(5):608-14
pubmed: 17435754
J Neurosci. 2012 May 2;32(18):6391-410
pubmed: 22553043
Neuroreport. 1996 Jan 31;7(2):441-5
pubmed: 8730801
J Neurosci Res. 2005 Jan 1-15;79(1-2):157-65
pubmed: 15573410
Free Radic Biol Med. 2015 Nov;88(Pt B):93-100
pubmed: 26117331
Cell Death Dis. 2021 Feb 26;12(2):218
pubmed: 33637689
J Neurosci. 1996 Apr 15;16(8):2553-62
pubmed: 8786431
Sci Rep. 2018 Aug 22;8(1):12552
pubmed: 30135571
Exp Neurol. 2020 Mar;325:113142
pubmed: 31812555
Neurobiol Aging. 2006 Feb;27(2):252-61
pubmed: 16399210
J Neurochem. 2006 Apr;97(2):373-84
pubmed: 16539673
Annu Rev Pharmacol Toxicol. 2013;53:401-26
pubmed: 23294312
J Neurosci Res. 1989 Oct;24(2):143-52
pubmed: 2585542
Nat Rev Neurol. 2014 Apr;10(4):217-24
pubmed: 24638131
Int J Mol Sci. 2016 Jul 13;17(7):
pubmed: 27420057
Redox Biol. 2017 Apr;11:543-553
pubmed: 28104575
Neurobiol Aging. 2015 Feb;36(2):583-91
pubmed: 25448601
Free Radic Biol Med. 2005 Mar 1;38(5):655-64
pubmed: 15683721
Biochim Biophys Acta. 2015 Apr;1850(4):794-801
pubmed: 25484314
Front Mol Neurosci. 2019 Feb 22;12:40
pubmed: 30853890
FASEB J. 2013 Jan;27(1):187-98
pubmed: 23038755
J Neurochem. 2001 Jun;77(6):1601-10
pubmed: 11413243
Neuron. 2014 Jan 22;81(2):229-48
pubmed: 24462092
Glia. 2020 May;68(5):1046-1064
pubmed: 31841614
Nat Neurosci. 2021 Mar;24(3):312-325
pubmed: 33589835
Ann Neurol. 2021 Feb;89(2):212-225
pubmed: 33068037
Biochem J. 2012 Apr 1;443(1):3-11
pubmed: 22417747
Oxid Med Cell Longev. 2011;2011:689524
pubmed: 21904646
Cell. 2019 May 30;177(6):1522-1535.e14
pubmed: 31130380
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9633-8
pubmed: 24979790
Glia. 2007 Sep;55(12):1263-71
pubmed: 17659525
Br J Clin Pharmacol. 2013 Apr;75(4):907-18
pubmed: 23126226
J Neurosci. 2003 Apr 15;23(8):3394-406
pubmed: 12716947
Nature. 2016 Jul 27;535(7613):551-5
pubmed: 27466127
Nat Neurosci. 2007 May;10(5):615-22
pubmed: 17435755
Mol Cancer Ther. 2016 Dec;15(12):3000-3014
pubmed: 27638861
Antioxid Redox Signal. 2011 Apr 15;14(8):1421-4
pubmed: 20977364
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13063-13068
pubmed: 27799543
EMBO Mol Med. 2019 Feb;11(2):
pubmed: 30617153
Mol Cell Biol. 2003 Oct;23(20):7198-209
pubmed: 14517290
J Biol Chem. 2010 Jul 16;285(29):22576-91
pubmed: 20452972
Nature. 2016 Apr 14;532(7598):195-200
pubmed: 27027288
Mutat Res. 2010 Aug 7;690(1-2):40-9
pubmed: 19748514
Neurochem Res. 2005 Oct;30(10):1311-8
pubmed: 16341593
Front Pharmacol. 2012 Jun 26;3:120
pubmed: 22740833
Neuron. 2015 Jan 7;85(1):101-115
pubmed: 25533482
J Neurosci. 2012 Dec 5;32(49):17775-87
pubmed: 23223297
Nature. 2013 Dec 19;504(7480):394-400
pubmed: 24270812
Nat Commun. 2015 May 13;6:7066
pubmed: 25967870
J Neurotrauma. 2001 Mar;18(3):351-9
pubmed: 11284554
Proc Natl Acad Sci U S A. 2014 May 6;111(18):E1818-20
pubmed: 24753562
Endocrinology. 2010 May;151(5):2381-7
pubmed: 20211971
Neuron. 2017 Nov 1;96(3):697-708
pubmed: 29096081
J Neurochem. 1994 Jan;62(1):45-53
pubmed: 7903354
J Neurophysiol. 2013 Jun;109(11):2803-14
pubmed: 23486205
J Cereb Blood Flow Metab. 2018 Aug;38(8):1354-1370
pubmed: 28606007
Cell Death Differ. 2015 Nov;22(11):1877-89
pubmed: 25909891

Auteurs

Zoeb Jiwaji (Z)

UK Dementia Research Institute at the University of Edinburgh, Chancellor's Building, Edinburgh Medical School, EH16 4SB, UK; Centre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK.

Giles E Hardingham (GE)

UK Dementia Research Institute at the University of Edinburgh, Chancellor's Building, Edinburgh Medical School, EH16 4SB, UK; Centre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK. Electronic address: Giles.Hardingham@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH